- 03-390 Phase II study of bevacizumab with gemcitabine and oxaliplatin in HCC. Andrew Zhu, Keith Sutart and Charles Fuchs.
- 02-025 Ph I Bevacizumab with 5-FU and radiation therapy in Rectal Cancer. Jeffrey Clark and Charles Fuchs.
- 02-317 Oral SU011 in patients with metastatic carcinoid or pancreatic neuroendocrine tumors. Matthew Kulke, Keith Stuart and David Ryan.
- Understanding racial disparities in colon cancer outcomes. John Ayanian (J. Clin Oncol 2003)